| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
2,080,000 |
| Market
Cap: |
1.49(M) |
| Last
Volume: |
1,523,296 |
Avg
Vol: |
1,519,084 |
| 52
Week Range: |
$0.714 - $0.714 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sonoma Pharmaceuticals is a global healthcare provider for developing and producing stabilized hypochlorous acid products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. Co.'s products include: Celacyn® Scar Management Gel, which provides scar management by protecting and moisturizing wound and scar sites; Microcyn® Wound Care Management, which provides improved healing properties; Acuicyn™ Eyelid and Eyelash Hygiene, which provides eyelid and eyelash hygiene; and Microdacyn60® Oral Care, which supports the treatment of mouth and throat infections and the debridement and moistening of mouth lesions and thrush.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Trombly Amy Moss |
Chief Executive Officer |
• – – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
213,648 |
|
- |
|
| Thornton Bruce |
Executive Vice President |
• – – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
216,781 |
|
- |
|
| Dvonch Jerome J |
Interim CFOOfficer |
• – – |
2023-04-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,009 |
|
- |
|
| Dal Poggetto John |
Chief Financial Officer |
• – – |
2020-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,086 |
3,201 |
|
- |
|
| Edwards Robert Grant |
Chief Financial Officer |
• – – |
2020-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,609 |
2,609 |
|
- |
|
| Dal Poggetto John |
Chief Financial OfficerOfficer |
• – – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
115 |
|
- |
|
| Harrison Russell Joseph |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,538 |
46,520 |
|
- |
|
| Mclaughlin John |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,781 |
48,728 |
|
- |
|
| Birnbaum Jay E |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,052 |
51,659 |
|
- |
|
| Miller Robert E |
Chief Financial Officer |
• – – |
2018-03-13 |
4 |
B |
$4.10 |
$4,920 |
I/I |
1,200 |
18,868 |
1.91 |
- |
|
| Miller Robert E |
Chief Financial Officer |
• – – |
2018-03-12 |
4 |
B |
$4.03 |
$4,836 |
I/I |
1,200 |
17,668 |
1.91 |
- |
|
| Miller Robert E |
Chief Financial Officer |
• – – |
2018-03-12 |
4 |
B |
$4.03 |
$4,836 |
I/I |
1,200 |
16,468 |
1.91 |
- |
|
| Miller Robert E |
Chief Financial Officer |
• – – |
2018-03-09 |
4 |
B |
$3.90 |
$4,680 |
I/I |
1,200 |
15,268 |
1.91 |
- |
|
| Schutz James J |
Chief Executive Officer |
• • – |
2018-03-08 |
4 |
B |
$3.99 |
$9,867 |
D/D |
2,473 |
35,858 |
2.81 |
- |
|
| Birnbaum Jay E |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,157 |
50,607 |
|
- |
|
| Mclaughlin John |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,958 |
46,947 |
|
- |
|
| Harrison Russell Joseph |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,691 |
44,982 |
|
- |
|
| Barbari Sharon Surrey |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,424 |
43,417 |
|
- |
|
| Schutz James J |
Chief Executive Officer |
• • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,211 |
33,385 |
|
- |
|
| Mclaughlin John |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,211 |
44,989 |
|
- |
|
| Barbari Sharon Surrey |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,211 |
41,993 |
|
- |
|
| Harrison Russell Joseph |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,211 |
43,291 |
|
- |
|
| Birnbaum Jay E |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,817 |
49,450 |
|
- |
|
| Schutz James J |
Chief Executive Officer |
• • – |
2017-11-30 |
4 |
B |
$4.95 |
$1,708 |
D/D |
345 |
16,174 |
2.73 |
- |
|
| Harrison Russell Joseph |
Director |
– • – |
2017-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
14,130 |
26,080 |
|
- |
|
115 Records found
|
|
Page 1 of 5 |
|
|
